By Sneha S K and Puyaan Singh (Reuters) -Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's ...
Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...
Relatively inexpensive and accessible self-management interventions to help people manage type 2 diabetes have been found to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback